STIMULATION OF ACTH CORTISOL BY INTRAVENOUSLY INFUSED SUBSTANCE-P IN NORMAL MEN - INHIBITION BY SODIUM VALPROATE

被引:28
作者
COIRO, V
CAPRETTI, L
VOLPI, R
DAVOLI, C
MARCATO, A
CAVAZZINI, U
CAFFARRI, G
ROSSI, G
CHIODERA, P
机构
[1] UNIV PARMA,INTERNAL MED CLIN,I-43100 PARMA,ITALY
[2] UNIV PARMA,SCH MED,ENDOCRINOL CLIN,I-43100 PARMA,ITALY
[3] HOSP CODOGNO,ENDOCRINE UNIT,CODOGNO,ITALY
[4] HOSP CREMONA,DIV INTERNAL MED,CREMONA,ITALY
[5] HOSP FIORENZUOLA,DIV INTERNAL MED,FIORENZUOLA,ITALY
[6] HOSP GUASTALLA,BIOCHEM LAB,GUASTALLA,ITALY
关键词
SODIUM VALPROATE; SUBSTANCE-P; ACTH; CORTISOL;
D O I
10.1159/000126262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of synthetic substance P (SP), infused intravenously in doses of 0.5, 1 or 1.5 pmol/kg-1/min-1 over 60 min on ACTH/cortisol secretion was evaluated in 7 healthy men. SP tests and a control test with normal saline were randomly performed at weekly intervals. During tests, SP infusion did not produce untoward side effects or changes in blood pressure. Plasma ACTH and cortisol levels were not modified when normal saline or the lowest dose of SP were infused, whereas they were significantly increased in a dose-dependent fashion when higher amounts of SP were administered. Further studies were performed in another 7 healthy men to test the possible influence of GABAergic neurotransmission on the ACTH/cortisol response to SP. For this purpose, subjects were tested with SP (1.5 pmol/kg-1/min-1) alone and on a different occasion with SP after pretreatment with the GABAergic agent sodium valproate (200 mg 16, 8 and 1 h before the SP test). Again, the administration of SP induced a significant increase in plasma ACTH and cortisol levels. The pretreatment with sodium valproate completely abolished both ACTH and cortisol responses to SP. These data demonstrate for the first time in humans that the systemic infusion of SP stimulates ACTH/cortisol secretion, suggesting the involvement of a GABAergic mechanism in the regulation of the action of SP.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 23 条
  • [1] CORTICOTROPIN, CORTISOL, PROLACTIN AND GROWTH-HORMONE RESPONSES TO INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL SUBJECTS GIVEN SODIUM VALPROATE
    ABRAHAM, RR
    DORNHORST, A
    WYNN, V
    ALTAHER, ARH
    CAMPBELL, EA
    BECKFORD, U
    WATTS, SM
    NICHOLSON, SA
    GILLHAM, B
    THODY, A
    JONES, MT
    [J]. CLINICAL ENDOCRINOLOGY, 1985, 22 (05) : 639 - 644
  • [2] EFFECTS OF GAMMA-AMINOBUTYRIC-ACID RECEPTOR AGONISTS ON THE SECRETION OF GROWTH-HORMONE, LUTEINIZING-HORMONE, ADRENOCORTICOTROPIC HORMONE AND THYROID-STIMULATING HORMONE FROM THE RAT PITUITARY-GLAND INVITRO
    ANDERSON, RA
    MITCHELL, R
    [J]. JOURNAL OF ENDOCRINOLOGY, 1986, 108 (01) : 1 - 8
  • [3] ARONIN N, 1986, ANNU REV PHYSIOL, V48, P537
  • [4] BROCK P, 1978, CLIN CHEM, V24, P1595
  • [5] SUBSTANCE-P STIMULATES ARGININE VASOPRESSIN AND INHIBITS ADRENOCORTICOTROPIN RELEASE INVIVO IN THE RAT
    CHOWDREY, HS
    JESSOP, DS
    LIGHTMAN, SL
    [J]. NEUROENDOCRINOLOGY, 1990, 52 (01) : 90 - 93
  • [6] FLUSHING AND PLASMA SUBSTANCE-P CONCENTRATION DURING INFUSION OF SYNTHETIC SUBSTANCE-P IN NORMAL MAN
    DEMUCKADELL, OBS
    AGGESTRUP, S
    STENTOFT, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (04) : 498 - 502
  • [7] REGULATORY ROLE OF GAMMA-AMINOBUTYRIC ACID IN PITUITARY-HORMONE SECRETION
    ELIAS, AN
    VALENTA, LJ
    SZEKERES, AV
    GROSSMAN, MK
    [J]. PSYCHONEUROENDOCRINOLOGY, 1982, 7 (01) : 15 - 30
  • [8] INHIBITION OF CRH-41 RELEASE BY SUBSTANCE-P, BUT NOT SUBSTANCE-K, FROM THE RAT HYPOTHALAMUS INVITRO
    FARIA, M
    NAVARRA, P
    TSAGARAKIS, S
    BESSER, GM
    GROSSMAN, AB
    [J]. BRAIN RESEARCH, 1991, 538 (01) : 76 - 78
  • [9] EFFECTS OF DI-N-PROPYLACETATE AN ANTICONVULSIVE COMPOUND ON GABA METABOLISM
    GODIN, Y
    HEINER, L
    MARK, J
    MANDEL, P
    [J]. JOURNAL OF NEUROCHEMISTRY, 1969, 16 (06) : 869 - &
  • [10] NEURO-ENDOCRINE EFFECTS OF CHRONIC ADMINISTRATION OF SODIUM VALPROATE IN EPILEPTIC PATIENTS
    INVITTI, C
    DANESI, L
    DUBINI, A
    CAVAGNINI, F
    [J]. ACTA ENDOCRINOLOGICA, 1988, 118 (03): : 381 - 388